QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (44) Citing Articles via Google Scholar Google Scholar Articles by Taylor, D. L. Articles by Pocock, J. M. Search for Related Content PubMed PubMed Citation Articles by Taylor, D. L. Articles by Pocock, J. M.

 Previous Article  |  Next Article 

The Journal of Neuroscience, March 15, 2003, 23(6):2150

Activation of Microglial Group III Metabotropic Glutamate Receptors Protects Neurons against Microglial Neurotoxicity

Deanna L. Taylor¹, Lara T. Diemel², and Jennifer M. Pocock¹

¹ Cell Signalling Laboratory and ² Laboratory of Experimental Neuroinflammation, Department of Neuroinflammation, Institute of Neurology, University College London, London, WC1N 1PJ, United Kingdom

A reduction in microglial activation and subsequent neurotoxicity may prove critical for neuroprotection in neurodegenerative diseases. We examined the expression and functionality of group III metabotropic glutamate (mGlu) receptors on microglia. Rat microglia express mRNA and receptor protein for group III mGlu receptors mGlu4, mGlu6, and mGlu8 but not mGlu7. Activation of these receptors on microglia with the specific group III agonists (L)-2-amino-4-phosphono-butyric acid (L-AP-4) or (R,S)-phosphonophenylglycine (RS-PPG) inhibited forskolin-induced cAMP production, linking these receptors to the negative inhibition of adenylate cyclase. These agonists did not induce a fall in mitochondrial membrane potential or apoptosis in the microglia, suggesting that activation of these receptors is not in itself toxic to microglia. Fluorescence-activated cell sorting analysis revealed that activation of group III mGlu receptors induces a mild activation of the microglia, as evidence by their enhanced staining with ED1. However, this activation is not neurotoxic. Agonists of group III mGlu receptors reduced microglial reactivity when they were activated with lipopolysaccharide (LPS), chromogranin A (CGA) or amyloid  peptide 25-35 (A25-35). Furthermore, L-AP-4 or RS-PPG treatment of microglia reduced their neurotoxicity after microglial stimulation with LPS or CGA but not A25-35. Similar results were obtained with microglial conditioned medium or in coculture, suggesting that the activation of microglial group III mGlu receptors may modulate the production of stable neurotoxins from the microglia. These results suggest that selective modulation of microglial group III mGlu receptors may provide a therapeutic target in neuroinflammatory diseases such as Alzheimer's disease.

Key words: neurodegenerative disease; Alzheimer's disease; microglia; neurotoxicity; metabotropic glutamate receptors; neuroprotection

---

Copyright © 2003 Society for Neuroscience  0270-6474/03/2362150-11$05.00/0

This article has been cited by other articles:

				D. J. Loane, B. A. Stoica, A. Pajoohesh-Ganji, K. R. Byrnes, and A. I. Faden Activation of Metabotropic Glutamate Receptor 5 Modulates Microglial Reactivity and Neurotoxicity by Inhibiting NADPH Oxidase J. Biol. Chem., June 5, 2009; 284(23): 15629 - 15639. [Abstract] [Full Text] [PDF]

				A. C. Vernon, V. Zbarsky, K. P. Datla, D. T. Dexter, and M. J. Croucher Selective Activation of Group III Metabotropic Glutamate Receptors by L-(+)-2-Amino-4-phosphonobutryic Acid Protects the Nigrostriatal System against 6-Hydroxydopamine Toxicity in Vivo J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 397 - 409. [Abstract] [Full Text] [PDF]

				D. L. Taylor, F. Jones, E. S. F. C. S. Kubota, and J. M. Pocock Stimulation of Microglial Metabotropic Glutamate Receptor mGlu2 Triggers Tumor Necrosis Factor {alpha}-Induced Neurotoxicity in Concert with Microglial-Derived Fas Ligand J. Neurosci., March 16, 2005; 25(11): 2952 - 2964. [Abstract] [Full Text] [PDF]

				R. B. Rock, G. Gekker, S. Hu, W. S. Sheng, M. Cheeran, J. R. Lokensgard, and P. K. Peterson Role of Microglia in Central Nervous System Infections Clin. Microbiol. Rev., October 1, 2004; 17(4): 942 - 964. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help